Profile picture

Doctor David Nanchen

University of Lausanne, Lausanne (Switzerland)
Membership: ESC Professional Member
Follow
Biography
David Nanchen is associate professor at the Faculty of biology and medicine of the University of Lausanne, and a specialist in general internal medicine in the Center for primary care and public health (Unisanté) in Lausanne, Switzerland . David Nanchen is head of the cardiovascular prevention clinic including cholesterol, tobacco, physical activity and diet management. He is an executive member of the Swiss Atherosclerosis Association www.gsla.ch. David Nanchen was trained in epidemiology and clinical research at the Erasmus University in Rotterdam. He is the initiator of the Swiss genetic screening program for familial hypercholesterolemia https:// catch.unisanté.ch. He studies biological markers, socio-economic aspects and therapeutic managment of cardiovascular risk through his involvement in several cohort studies and clinical trials. In parallel to his passion for medicine and science, he is a contemplative of the mountains that he hikes, bikes or skis, with family and friends.
Logo ESC

Contributor content

Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study
Presentation
Contemporary LDL-cholesterol management in male and female patients at high-cardiovascular risk: results from the European observational SANTORINI study
Participation rate and yield of indirect cascade genetic screening for familial hypercholesterolemia using a web-based communication platform (CATCH): a randomized multicenter implementation trial
Presentation
Participation rate and yield of indirect cascade genetic screening for familial hypercholesterolemia using a web-based communication platform (CATCH): a randomized multicenter implementation trial
Comparison of severe hypercholesterolemia patients with and without pathogenic variants
Presentation
Comparison of severe hypercholesterolemia patients with and without pathogenic variants
Effectiveness, adherence and safety of evolocumab in a Swiss multicenter prospective observational study
Presentation
Effectiveness, adherence and safety of evolocumab in a Swiss multicenter prospective observational study
Prognosis of patients with clinical familial hypercholesterolemia after acute coronary syndrome
Presentation
Prognosis of patients with clinical familial hypercholesterolemia after acute coronary syndrome

ESC 365 is supported by